Sarcoma response to targeted therapy dynamically polarizes tumor-associated macrophages

5Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In gastrointestinal stromal tumor (GIST ), the most common human sarcoma, tumor-associated macrophages (TAMs) have been found to be abundant and surprisingly M1-like, exhibiting antitumoral activities. However, TAMs switch to M2-like during the course of imatinib therapy, but upon drug resistance TAMs revert to M1-like. Therefore, the oncologic efficacy of TAM depletion may depend on tumor type and treatment status. ©2014 Landes Bioscience.

Cite

CITATION STYLE

APA

Cavnar, M. J., & DeMatteo, R. P. (2014). Sarcoma response to targeted therapy dynamically polarizes tumor-associated macrophages. OncoImmunology. Landes Bioscience. https://doi.org/10.4161/onci.28463

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free